Valuation: IRIDEX Corporation

Market Cap 15.93M 13.96M 12.97M 11.91M 22.44M 1.54B 22.79M 154M 60.38M 752M 59.79M 58.5M 2.6B P/E 2026 *
-18.3x
P/E 2027 * 45.8x
Enterprise Value 15.93M 13.96M 12.97M 11.91M 22.44M 1.54B 22.79M 154M 60.38M 752M 59.79M 58.5M 2.6B EV / Sales 2026 *
0.3x
EV / Sales 2027 * 0.28x
Free-Float
62.93%
Yield 2026 *
-
Yield 2027 * -
1 week-14.48%
Current month-20.08%
1 month-19.02%
3 months-14.48%
6 months-41.34%
Current year-19.73%
1 week 0.89
Extreme 0.89
0.99
1 month 0.89
Extreme 0.89
1.2
Current year 0.89
Extreme 0.89
1.65
1 year 0.87
Extreme 0.8688
1.65
3 years 0.78
Extreme 0.782
3.65
5 years 0.78
Extreme 0.782
9.46
10 years 0.78
Extreme 0.782
16.51
Manager TitleAgeSince
Chief Executive Officer 54 2024-09-30
Director of Finance/CFO 68 2018-12-17
Investor Relations Contact - -
Director TitleAgeSince
Chairman 60 2020-06-23
Director/Board Member 54 2018-08-31
Director/Board Member 66 2022-03-16
Date Insider Type Main position Quantity % Market Cap.
7/10/26 Free

Chief Executive Officer

400,000 2.2980%
7/10/26 Free

Chief Financial Officer

200,000 1.1490%
6/13/26 Tax

Chief Executive Officer

-3,990 0.0229%
Change 5-day change 1-year change 3-year change Capi.($)
0.00%-14.48%-27.37%-55.58% 15.93M
+0.57%-1.42%+30.01%-6.36% 195B
+0.07%-10.00%-4.75%-29.99% 126B
-2.68%-10.23%-33.99%+1.20% 124B
-0.51%+0.80%-58.60%-19.17% 64.2B
-0.21%-6.35%+10.20%-8.86% 48.68B
+0.17%+0.82%-24.52%-32.66% 43.83B
+0.45%-1.29%+19.12%+4.58% 37.52B
+0.89%-1.48%+31.66%+28.44% 36.09B
-0.86%-0.17%+101.35%+0.20% 29.13B
Average +0.17%-4.22%+4.31%-11.82% 70.38B
Weighted average by Cap. +0.36%-3.83%+2.13%-9.59%

Financials

2026 *2027 *
Net sales 53M 46.45M 43.16M 39.63M 74.66M 5.12B 75.82M 514M 201M 2.5B 199M 195M 8.64B 56.77M 49.75M 46.22M 42.44M 79.96M 5.48B 81.21M 550M 215M 2.68B 213M 208M 9.26B
Net income -795K -697K -647K -594K -1.12M -76.76M -1.14M -7.71M -3.01M -37.53M -2.98M -2.92M -130M 361K 316K 294K 270K 509K 34.86M 516K 3.5M 1.37M 17.04M 1.36M 1.33M 58.88M
Net Debt - -
Logo IRIDEX Corporation
IRIDEX Corporation is an ophthalmic medical technology company. The Company is developing, manufacturing, and marketing versatile laser-based medical systems, delivery devices and consumable instrumentation. Its MicroPulse Technology and Endpoint Management Technology are used for the treatment of glaucoma and retina disorders. Its laser consoles product consists of Glaucoma, Medical Retina and Surgical Retina. Its glaucoma console line is the Cyclo G6 laser system with MicroPulse technology. Its surgical-retina product line includes its OcuLight TX and OcuLight SLx laser photocoagulation systems. Its medical-retina product line includes its portable IQ 532 and IQ 577 laser systems. Its laser probe products include Glaucoma and Surgical Retina. Probes used in its glaucoma product line include its patented single-use delivery devices-MicroPulse P3, G-Probe, and G-Probe Illuminate. Probes used in its surgical retina product line include its family of single-use EndoProbe handpieces.
Employees
93
Date Price Change Volume
26-07-22 US$0.9151 0.00% 18,730
26-07-21 US$0.9151 -1.13% 40,339
26-07-20 US$0.9256 -0.94% 57,581
26-07-17 US$0.9344 -1.75% 22,908
26-07-16 US$0.9510 -9.43% 263,182
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
1
Last Close Price
0.9151USD
Average target price
2.750USD
Spread / Average Target
+200.51%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. IRIX Stock